ClinConnect ClinConnect Logo
Search / Trial NCT05480956

SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jul 27, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

The SIRI Checklist study is focused on improving HIV prevention and treatment for people living in rural areas who inject drugs. Researchers want to use a new checklist to help ensure that these individuals receive the right care, including long-acting injectable medicines that can prevent HIV. The main idea is that better hospital care can help connect people who use drugs to effective treatments for both addiction and the prevention of infections like HIV, ultimately helping to end the HIV epidemic in rural areas.

To be part of this study, participants need to be at least 18 years old, have a serious injection-related infection, and be receiving care at UAB Hospital. They must be HIV negative and have a diagnosis of opioid use disorder, which means they struggle with using opioids. Participants will be engaged in a supportive environment where they can receive care tailored to their needs. This research is important because it aims to create effective strategies for helping vulnerable populations access the healthcare they need.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • We will include 60 PWUD with serious injection related infections (SIRI) who are HIV negative, ≥ 18 years old, have opioid use disorder (OUD) and receiving care at UAB Hospital
  • Exclusion Criteria:
  • We will exclude those unable to provide informed consent due to acute illness or intoxication, those who don't have OUD, and those who are HIV positive in order to inform HIV prevention interventions.

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials